215 results on '"Kawai, Yohko"'
Search Results
2. Safety and efficacy of edoxaban in patients undergoing hip fracture surgery
3. Neutrophil elastase and systemic inflammatory response syndrome in the initiation and development of acute lung injury among critically ill patients
4. TOWARD A REFERENCE METHOD FOR LEUKOCYTE DIFFERENTIAL COUNTS IN BLOOD FOR EVALUATION OF AUTOMATED HEMATOLOGY ANALYZERS: VALIDATION OF FLOWCYTOMETRIC JSLH DIFF METHOD AND SOP: 315
5. LONGITUDINAL EVALUATION OF HEMATOLOGICAL VALUES OBATAINED WITH REFERENCE AUTOMATED HEMATOLOGY ANALYZERS OF SIX MANUFACTURERES (2013): 812
6. 2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants
7. EVALUATION OF HEMATOLOGICAL VALUES OBTAINED WITH REFERENCE AUTOMATED HEMATOLOGY ANALYZERS OF SIX MANUFACTURERS (JSLH SURVEY): AM100
8. Immune checkpoint therapy in proteinuric kidney disease
9. Competitive reverse transcription-polymerase chain reaction assay for quantification of human multidrug resistance 1 (MDR1) gene expression in fresh leukemic cells
10. Novel point mutations in the alpha IIb subunit (Phe289 [arrow right] Ser, Glu324 [arrow right] Lys and Gln747 [arrow right] Pro) causing thrombasthenic phenotypes in four Japanese patients
11. The role of the D1 domain of the von Willebrand factor propeptide in multimerization of VWF
12. Expert consensus regarding standardization of sample preparation for clotting time assays.
13. Low Shear Stress Can Initiate von Willebrand Factor-dependent Platelet Aggregation in Patients with Type IIB and Platelet-type von Willebrand Disease
14. International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants
15. 1,25-Dihydroxyvitamin D3 Induces Differentiation of a Retinoic Acid–Resistant Acute Promyelocytic Leukemia Cell Line (UF-1) Associated With Expression of p21WAF1/CIP1 and p27KIP1
16. Additional file 1: Table S1. of Edoxaban versus enoxaparin for the prevention of venous thromboembolism after total knee or hip arthroplasty: pooled analysis of coagulation biomarkers and primary efficacy and safety endpoints from two phase 3 trials
17. Edoxaban versus enoxaparin for the prevention of venous thromboembolism after total knee or hip arthroplasty: pooled analysis of coagulation biomarkers and primary efficacy and safety endpoints from two phase 3 trials
18. Multianalyte Conventional Reference Material (MacRM): A Useful Tool for Nationwide Standardization of Laboratory Measurements for Medical Care—A Model Study in Japan
19. Difference in lipids between two similar strains ofPseudomonas pertucinogena and possibility of the presence of lysocardiolipin as a normal phospholipid constituent of its membrane
20. Efficacy and safety of edoxaban versus enoxaparin for the prevention of venous thromboembolism following total hip arthroplasty: STARS J-V
21. A randomized, open-label trial of edoxaban in Japanese patients with severe renal impairment undergoing lower-limb orthopedic surgery
22. A new type of phosphoglycolipid fromPseudomonas cepacia
23. Epitope Mapping for Monoclonal Antibody Reveals the Activation Mechanism for αVβ3 Integrin
24. Divalent Cations Define the Structural Requirements for αIIbβ3 Integrin Activation
25. Edoxaban Versus Enoxaparin for the Prevention of Venous Thromboembolism: Pooled Analysis of Coagulation Biomarkers From Stars E-3 and Stars J-V.
26. Randomized, Multicenter, Warfarin-Controlled Phase II Study of Edoxaban in Japanese Patients With Non-Valvular Atrial Fibrillation
27. Edoxaban Versus Enoxaparin for the Prevention of Venous Thromboembolism: Pooled Analysis of Venous Thromboembolism and Bleeding From STARS E-3 and STARS J-V
28. The Guideline for Laboratory Medicine, JSLM2009.
29. Structural Requirements for Activation in αIIbβ3 Integrin
30. Regulatory Role of the Extracellular α-Tail/β-Tail Interaction in αIIbβ3 Integrin Activation
31. Efficacy and Safety of Edoxaban Versus Enoxaparin for the Prevention of Venous Thromboembolism Following Total Hip Arthroplasty: STARS J-V trial
32. Edoxaban in Patients Undergoing Total Hip Arthroplasty: A Phase IIb Dose-Finding Study.
33. Asymptomatic Intracranial Hemorrhage Among Japanese Patients Taking Edoxaban for Non-Valvular Atrial Fibrillation.
34. Randomized, Double-Blind, Multi-Dose Efficacy, Safety and Biomarker Study of the Oral Factor Xa Inhibitor DU-176b Compared with Placebo for Prevention of Venous Thromboembolism in Patients after Total Knee Arthroplasty
35. Inhibition of Cellular Adhesion in Human Umbilical Vein Endothelial Cells by NF-κB Inhibitor DHMEQ Under Flow
36. Development of a Diagnostic Support System for Hematological Disorders Using a Self-Organizing Map.
37. Molecular basis for lipopolysaccharide mimetic action of Taxol™ and flavolipin
38. Japanese Journal of Thrombosis and Hemostasis
39. Japanese Journal of Thrombosis and Hemostasis
40. The partially degraded lipopolysaccharide ofBurkholderia cepaciaand ornithine-containing lipids derived from some Gram-negative bacteria are useful complex lipid adjuvants
41. Toll-Like Receptor 4-MD-2 Complex Mediates the Signal Transduction Induced by Flavolipin, an Amino Acid-Containing Lipid Unique to Flavobacterium meningosepticum
42. Inhibition of platelet aggregation by clopidogrel sulfate: Dose-finding clinical pharmacology study
43. Development of acute erythremia from myelodysplastic syndrome after treatment with 1,25-dihydroxyvitamin D3
44. Modulation of chemotaxis, O2âproduction and myeloperoxidase release from human polymorphonuclear leukocytes by the ornithine-containing lipid and the serineglycine-containing lipid ofFlavobacterium
45. Ornithine-containing lipids stimulate CD14-dependent TNF-α production from murine macrophage-like J774.1 and RAW 264.7 cells
46. A typical bacterial ornithine-containing lipidNα-(d)-[3-(hexadecanoyloxy)hexadecanoyl]-ornithine is a strong stimulant for macrophages and a useful adjuvant
47. Three Novel Integrin β3 Subunit Missense Mutations (H280P, C560F, and G579S) in Thrombasthenia, Including One (H280P) Prevalent in Japanese Patients
48. Revised structure and synthesis of flavolipin
49. Novel point mutations in the αIIb subunit (Phe289 → Ser, Glu324 → Lys and Gln747 → Pro) causing thrombasthenic phenotypes in four Japanese patients
50. Fluid Shear Stress Attenuates Tumor Necrosis Factor-α–Induced Tissue Factor Expression in Cultured Human Endothelial Cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.